Inventor
STAGLIANO NANCY E
US32 patents
⚠️ This page may combine multiple inventors who share the name “STAGLIANO NANCY E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IPIERIAN INC
8 patentsUS8980270B2Mar 17, 2015
Methods of treating a tauopathy
IPIERIAN INC33 citations96
US9051367B2Jun 9, 2015
Methods of treating a tauopathy
IPIERIAN INC33 citations93
US8980271B2Mar 17, 2015
Methods of treating a tauopathy
IPIERIAN INC32 citations93
US8926974B2Jan 6, 2015
Methods of treating a tauopathy
IPIERIAN INC45 citations92
US9777058B2Oct 3, 2017
Methods of treating a tauopathy
IPIERIAN INC12 citations91
US9567395B2Feb 14, 2017
Methods of treating a tauopathy
IPIERIAN INC16 citations91
US9447180B2Sep 20, 2016
Methods of treating a tauopathy
IPIERIAN INC15 citations91
US10040847B2Aug 7, 2018
Methods of treating a tauopathy
IPIERIAN INC6 citations83
TRUE NORTH THERAPEUTICS INC
8 patentsUS8945562B2Feb 3, 2015
Anti-complement C1s antibodies
TRUE NORTH THERAPEUTICS INC24 citations96
US9562092B2Feb 7, 2017
Methods of inhibiting complement C4 activation with anti-complement C1s antibodies
TRUE NORTH THERAPEUTICS INC10 citations92
US9512233B2Dec 6, 2016
Anti-complement C1s antibodies and methods of inhibiting complement C1s activity
TRUE NORTH THERAPEUTICS INC12 citations92
US9206259B2Dec 8, 2015
Methods of inhibiting complement C4 activation with anti-complement C1S antibodies
TRUE NORTH THERAPEUTICS INC15 citations92
US9074003B2Jul 7, 2015
Methods of inhibiting activation of complement component C4 with anti-C1s antibodies
TRUE NORTH THERAPEUTICS INC15 citations92
US9074004B2Jul 7, 2015
Methods of inhibiting activation of complement component C4 with anti-C1s antibodies
TRUE NORTH THERAPEUTICS INC15 citations92
US8877197B2Nov 4, 2014
Anti-complement C1s
TRUE NORTH THERAPEUTICS INC22 citations92
US9562106B2Feb 7, 2017
Anti-complement C1s antibodies and methods of inhibiting complement C1s activity
TRUE NORTH THERAPEUTICS INC8 citations84
CYTOMX THERAPEUTICS INC
7 patentsUS9127053B2Sep 8, 2015
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC39 citations97
US10118961B2Nov 6, 2018
Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
CYTOMX THERAPEUTICS INC34 citations96
US9644016B2May 9, 2017
Soluble notch receptor proproteins and methods of use thereof
CYTOMX THERAPEUTICS INC34 citations96
US10301380B2May 28, 2019
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC17 citations94
US8993266B2Mar 31, 2015
Proproteins activatable interferon alpha
CYTOMX THERAPEUTICS INC28 citations94
US10513549B2Dec 24, 2019
Cleavage-activatable interferon-alpha proprotein
CYTOMX THERAPEUTICS INC14 citations93
US9688748B2Jun 27, 2017
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC11 citations84
BIOVERATIV USA INC
5 patentsUS10457745B2Oct 29, 2019
Anti-complement C1s antibodies
BIOVERATIV USA INC6 citations83
US10450382B2Oct 22, 2019
Anti-complement C1s antibodies
BIOVERATIV USA INC8 citations83
US12215169B2Feb 4, 2025
Anti-complement C1s antibodies and uses thereof
BIOVERATIV USA INC1 citations74
US12391750B2Aug 19, 2025
Anti-C1S antibodies and methods of use thereof
BIOVERATIV USA INC0 citations62
US12240917B2Mar 4, 2025
Anti-complement C1s antibodies and uses thereof
BIOVERATIV USA INC0 citations62
STAGLIANO NANCY E
3 patentsUS8563269B2Oct 22, 2013
Modified antibody compositions, methods of making and using thereof
STAGLIANO NANCY E119 citations97
US8513390B2Aug 20, 2013
Modified antibody compositions, methods of making and using thereof
STAGLIANO NANCY E111 citations97
US8399219B2Mar 19, 2013
Protease activatable interferon alpha proprotein
STAGLIANO NANCY E46 citations97